Tech Company Financing Transactions
Solexa Funding Round
On 9/27/2004, Solexa raised $14.4 million in Series B investment from Amadeus Capital, Abingworth and Oxford Bioscience Partners.
Transaction Overview
Company Name
Announced On
9/27/2004
Transaction Type
Venture Equity
Amount
$14,400,000
Round
Series B
Investors
Amadeus Capital (Lead Investor) (Hermann Hauser)
Proceeds Purpose
This new investment will be applied to the development of Solexa's revolutionary systems for the comprehensive, ultra-high throughput and economical analysis of individual genomes, based on its breakthrough single molecule-based sequencing technology. It will also enable the Company to begin commercialization of its services and systems on a global basis.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
25861 Industrial Boulevard
Hayward, CA 94545
USA
Hayward, CA 94545
USA
Phone
Website
Email Address
Not Recorded
Overview
Solexa, Inc. is developing and preparing to commercialize a new platform for genetic analysis, based on Sequencing-by-Synthesis (SBS) and Cluster molecular arrays. This one platform is expected to support many types of genetic analysis, including DNA sequencing, gene expression, genotyping and micro-RNA analysis.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John West
Browse more venture capital transactions:
Prev: 9/23/2004: Aristos Logic venture capital transaction
Next: 9/27/2004: Siliquent Technologies venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs